A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
Author:
Funder
Heed Ophthalmic Foundation
ONL Therapeutics
Research to Prevent Blindness
Publisher
Elsevier BV
Subject
Ophthalmology
Reference30 articles.
1. Evaluation of intravitreal aflibercept for the treatment of severe nonproliferative diabetic retinopathy: results From the PANORAMA randomized clinical trial;Brown;JAMA Ophthalmol,2021
2. Effect of intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity in patients with vitreous hemorrhage from proliferative diabetic retinopathy: a randomized clinical trial;Antoszyk;JAMA,2020
3. Effect of intravitreous anti-vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the Protocol W randomized clinical trial;Maturi;JAMA Ophthalmol,2021
4. Anti-vascular endothelial growth factor and panretinal photocoagulation use after protocol s for proliferative diabetic retinopathy;Azad;Ophthalmol Retina,2021
5. Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA;Nanegrungsunk;Curr Opin Ophthalmol,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Methylation in cornea and corneal diseases: a systematic review;Cell Death Discovery;2024-04-08
2. The Cost of Standard and Complex Pars Plana Vitrectomy for Retinal Detachment Repair Exceeds Its Reimbursement;Ophthalmology Retina;2023-11
3. Comment on: A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy;American Journal of Ophthalmology;2023-06
4. Comment on: Perspective: A Caveat About Financial Incentives for Anti−vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy;American Journal of Ophthalmology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3